Historical Ibogaine Media & Press Archives This is not a complete archive of ibogaine-related pieces from the 90s, it represents part of a collection of materials which were not accessible on the internet previously. In particular it focuses on the FDA and NIDA’s involvement during a period of time when…
Ibogaine related historical archive – Howard Lotsof’s Dora Weiner Foundation rebooted: http://doraweiner.com
PSYCHEDELIC SCIENCE – Documentary by Bill Eagles Aired on: February 27th, 1997, BBC NARRATOR (HUGH QUARSHIE): Controversial human experiments with the psychedelic drug LSD held new promise for psychiatry in the 1950s. They were closed down when the drug was made illegal in 1966. Today a new generation of American scientists…
Reload of ibogaine.mindvox.com site completed, all content pulled into updated framework and relaunched. The site you are on exists mostly as a historical archive. Content is not being actively updated. After a scheduled, brief, 16-year-long period of downtime for routine maintenance, MindVox.com was rebooted on December 21, 2012. This obviates the need for…
NCTR 2002-2003 Research Plans – Neurotoxicology Title: Effects of Ibogaine on Neurotransmitter Systems, Generation of Free Radicals and Nitric Oxide Synthase Activity: Correlation with Neurohistological Evaluations in Mouse and Rat Brain Determine the effects of ibogaine on dopamine, serotonin and their metabolite concentrations in different regions of mouse and rat…
Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to…
18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…
Ms. Iboga